2m 2m 2m 2m 2m 2m 2m
KRYSTAL BIOTECH (KRYS)
NASDAQ
$339.83-$3.61 (-1.05%)
Price as of Jun 23, 2026 7:16 PM EDT- $10.1BMarket Cap
- 149.01%1-Year Change
- BiotechnologyIndustry
KRYSTAL BIOTECH (KRYS)
$339.83-$3.61 (-1.05%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 389.1M +33.94% | 290.5M +473.02% | 50.7M N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 366.1M +35.36% | 270.5M +433.45% | 50.7M N/A | 0 N/A | |
Sales and Marketing Expense | 146.7M +29.08% | 113.7M N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -58.0M +8.35% | -53.6M +15.38% | -46.4M +9.35% | -42.5M +52.28% | |
Depreciation and Amortization Expense | 5.7M -4.07% | 6.0M +19.17% | 5.0M +23.48% | 4.1M +46.44% | |
Total Operating Expenses | 227.8M +1.34% | 224.8M +40.14% | 160.4M +10.49% | 145.2M +112.66% | |
Operating Profit | 161.3M +145.52% | 65.7M +159.87% | -109.7M -24.43% | -145.2M +112.66% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | 0 N/A | 0 +100.00% | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 +100.00% | |
Total Nonoperating Income and Expense | 28.2M -5.01% | 29.7M +31.10% | 22.6M +333.33% | 5.2M +209.12% | |
Income before Taxes | 189.5M +98.70% | 95.4M +639.37% | 12.9M +108.88% | -145.2M +112.66% | |
Income Taxes | -15.4M -347.86% | 6.2M +215.37% | 2.0M N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 204.8M +129.74% | 89.2M +715.58% | 10.9M +107.81% | -140.0M +101.20% | |
Net Income from Continuing Operations Applicable to Common | 189.5M +98.70% | 95.4M +639.37% | 12.9M +109.21% | -140.0M +101.20% | |
Basic EPS and Net Income | 7.08 +126.92% | 3.12 +680.00% | 0.40 +107.29% | -5.49 +75.40% | |
Diluted EPS and Net Income | 6.84 +128.00% | 3.00 +669.23% | 0.39 +107.10% | -5.49 +75.40% | |
Basic Weighted Average Shares | 28.9M +1.23% | 28.6M +5.29% | 27.2M +6.52% | 25.5M +14.84% | |
Diluted Weighted Average Shares | 30.0M +0.71% | 29.7M +7.16% | 27.8M +8.87% | 25.5M +14.84% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 496.3M +43.91% | 344.9M -3.76% | 358.3M +121.33% | 161.9M -52.56% | |
Short-Term Investments | 331.5M +31.20% | 252.7M +45.33% | 173.8M -19.98% | 217.3M +124.34% | |
Cash and Cash Equivalents and Short-Term Investments | 827.8M +38.54% | 597.5M +12.28% | 532.2M +40.35% | 379.2M -13.45% | |
Total Current Assets | 1.0B +38.08% | 742.0M +26.22% | 587.9M +53.19% | 383.8M -13.22% | |
Accumulated Depreciation | 31.3M +42.71% | 21.9M +70.88% | 12.8M +88.83% | 6.8M +61.20% | |
Property and Plant and Equipment and Net | 150.8M -2.83% | 155.2M -3.74% | 161.2M -0.30% | 161.7M +43.90% | |
Total Long-Term Assets | 287,000 +24.24% | 231,000 -12.17% | 263,000 -18.83% | 324,000 +337.84% | |
Total Assets | 1.3B +26.33% | 1.1B +29.02% | 818.4M +46.54% | 558.5M -10.83% | |
Income Taxes Payable | 10.9M +154.64% | 4.3M +87.82% | 2.3M +5,209.30% | 43,000 -48.19% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 102.9M +0.93% | 102.0M +208.20% | 33.1M +14.72% | 28.8M +12.09% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 3.7M +162.44% | 1.4M -78.56% | 6.6M -10.20% | 7.4M +5.57% | |
Total Liabilities | 114.2M +4.36% | 109.5M +175.62% | 39.7M +9.65% | 36.2M +10.70% | |
Retained Earnings | 24.2M +113.37% | -180.7M -33.04% | -269.8M -3.89% | -280.8M +99.43% | |
Total Stockholders Equity | 1.2B +28.87% | 946.4M +21.54% | 778.6M +49.10% | 522.2M -12.02% | |
Total Shares Outstanding | 29.2M +1.38% | 28.8M +1.97% | 28.2M +9.60% | 25.8M +2.20% | |
Cash Flow | |||||
Cash from Operating Activities | 200.9M +62.75% | 123.4M +238.98% | -88.8M -11.70% | -100.6M +109.79% | |
Capital Expenditures | 12.0M +182.00% | 4.2M -64.08% | 11.8M -77.73% | 53.0M -22.47% | |
Cash from Investing Activities | -58.4M -64.26% | -163.4M -297.78% | 82.6M +172.44% | -114.1M -49.69% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 8.7M -67.78% | 27.0M -86.68% | 202.8M +473.60% | 35.3M -89.83% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | 41.45% +83.30% | 22.61% +110.45% | -216.43% N/A | N/A N/A | |
Return on Assets | 17.14% +80.18% | 9.51% +499.14% | 1.59% +106.72% | -23.63% +59.15% | |
Return on Equity | 18.91% +82.97% | 10.34% +515.05% | 1.68% +106.70% | -25.09% +59.70% | |
Revenue Growth | 33.94% -92.82% | 473.02% N/A | N/A N/A | N/A N/A | |
Current Ratio | 9.95 +36.81% | 7.28 -59.05% | 17.76 +33.53% | 13.30 -22.58% | |
Cash Ratio | 4.82 +42.59% | 3.38 -68.77% | 10.83 +92.92% | 5.61 -57.67% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow